These results indicated that ILK facilitates ESCC cell proliferation and migration through the AKT signaling pathway by phosphorylation on Ser473 of AKT, rather than the GSK-3β pathway in our model systems. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.